10 XP 0   0   5  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

ATOS (Atossa Genetics Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze Atossa Genetics Inc together

I guess you are interested in Atossa Genetics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Atossa Genetics Inc’s Financial Insights
  • 📈 Technical Analysis (TA) – Atossa Genetics Inc’s Price Targets

I'm going to help you getting a better view of Atossa Genetics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Atossa Genetics Inc

I send you an email if I find something interesting about Atossa Genetics Inc.

1. Quick Overview

1.1. Quick analysis of Atossa Genetics Inc (30 sec.)










1.2. What can you expect buying and holding a share of Atossa Genetics Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
5.0%

What is your share worth?

Current worth
$0.51
Expected worth in 1 year
$0.35
How sure are you?
27.5%

+ What do you gain per year?

Total Gains per Share
$-0.16
Return On Investment
-16.9%

For what price can you sell your share?

Current Price per Share
$0.94
Expected price per share
$0.77 - $1.08
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Atossa Genetics Inc (5 min.)




Live pricePrice per Share (EOD)
$0.94
Intrinsic Value Per Share
$-1.63 - $-1.30
Total Value Per Share
$-1.12 - $-0.79

2.2. Growth of Atossa Genetics Inc (5 min.)




Is Atossa Genetics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$65.3m$94.9m-$22.3m-30.7%

How much money is Atossa Genetics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$6.5m-$7.4m$836.7k12.7%
Net Profit Margin0.0%-8,163.9%--

How much money comes from the company's main activities?

2.3. Financial Health of Atossa Genetics Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#383 / 872

Most Revenue
#817 / 872

Most Profit
#462 / 872

Most Efficient
#269 / 872
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Atossa Genetics Inc?

Welcome investor! Atossa Genetics Inc's management wants to use your money to grow the business. In return you get a share of Atossa Genetics Inc.

First you should know what it really means to hold a share of Atossa Genetics Inc. And how you can make/lose money.

Speculation

The Price per Share of Atossa Genetics Inc is $0.9366. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Atossa Genetics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Atossa Genetics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.51. Based on the TTM, the Book Value Change Per Share is $-0.04 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.05 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Atossa Genetics Inc.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.05-5.6%-0.05-5.4%-0.06-6.1%-0.05-5.8%-0.05-5.3%-0.04-4.2%
Usd Book Value Change Per Share-0.05-5.1%-0.04-4.2%-0.05-5.7%-0.05-4.8%0.022.2%0.011.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.4%0.000.2%
Usd Total Gains Per Share-0.05-5.1%-0.04-4.2%-0.05-5.7%-0.05-4.8%0.022.6%0.011.3%
Usd Price Per Share0.67-1.08-1.17-1.02-1.69-1.47-
Price to Earnings Ratio-3.23--5.29--5.38--4.78--10.07--2.12-
Price-to-Total Gains Ratio-14.12--31.80--23.43--24.83--18.11-5.11-
Price to Book Ratio1.33-1.90-1.62-1.45-6.28-14.29-
Price-to-Total Gains Ratio-14.12--31.80--23.43--24.83--18.11-5.11-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.9366
Number of shares1067
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.040.02
Usd Total Gains Per Share-0.040.02
Gains per Quarter (1067 shares)-42.2026.20
Gains per Year (1067 shares)-168.82104.79
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-169-179159095
20-338-34830180200
30-506-51745270305
40-675-68660360410
50-844-85574450515
60-1013-102489539620
70-1182-1193104629725
80-1351-1362119719830
90-1519-1531134809935
100-1688-17001498991040

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%1.039.00.02.5%1.058.00.01.7%
Book Value Change Per Share0.04.00.00.0%0.012.00.00.0%4.016.00.020.0%11.029.00.027.5%19.038.02.032.2%
Dividend per Share0.00.04.00.0%0.00.012.00.0%2.00.018.010.0%2.00.038.05.0%3.00.056.05.1%
Total Gains per Share0.04.00.00.0%0.012.00.00.0%4.016.00.020.0%11.029.00.027.5%19.038.02.032.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Atossa Genetics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.048-0.040-17%-0.053+12%-0.045-5%0.021-326%0.011-547%
Book Value Per Share--0.5060.563-10%0.735-31%0.746-32%0.735-31%0.400+26%
Current Ratio--12.67213.828-8%23.196-45%23.766-47%33.678-62%19.881-36%
Debt To Asset Ratio--0.0770.070+9%0.045+71%0.048+58%0.067+15%0.138-44%
Debt To Equity Ratio--0.0830.076+10%0.047+77%0.051+62%0.082+1%0.185-55%
Dividend Per Share----0%-0%-0%0.003-100%0.002-100%
Enterprise Value--146609495.692206881648.173-29%238159626.250-38%219415786.391-33%307596721.735-52%237020329.642-38%
Eps---0.052-0.051-2%-0.057+10%-0.055+5%-0.050-4%-0.039-25%
Free Cash Flow Per Share---0.046-0.043-7%-0.036-22%-0.041-11%-0.036-22%-0.027-42%
Free Cash Flow To Equity Per Share---0.046-0.036-21%-0.013-72%-0.019-59%0.036-229%0.023-302%
Gross Profit Margin--1.0001.0000%1.108-10%1.036-3%1.022-2%1.030-3%
Intrinsic Value_10Y_max---1.300----------
Intrinsic Value_10Y_min---1.628----------
Intrinsic Value_1Y_max---0.110----------
Intrinsic Value_1Y_min---0.166----------
Intrinsic Value_3Y_max---0.347----------
Intrinsic Value_3Y_min---0.498----------
Intrinsic Value_5Y_max---0.602----------
Intrinsic Value_5Y_min---0.830----------
Market Cap120980622.000+28%86918495.692139729648.173-38%151015876.250-42%131109703.058-34%218879856.835-60%189374522.442-54%
Net Profit Margin----0%-81.6390%-27.2130%-16.3280%-8.2990%
Operating Margin----0%-96.9440%-32.3150%-19.3890%-9.8280%
Operating Ratio----0%96.944-100%32.315-100%19.389-100%9.921-100%
Pb Ratio1.852+28%1.3311.905-30%1.620-18%1.455-9%6.277-79%14.291-91%
Pe Ratio-4.502-39%-3.235-5.295+64%-5.378+66%-4.778+48%-10.066+211%-2.125-34%
Price Per Share0.937+28%0.6731.082-38%1.169-42%1.015-34%1.695-60%1.466-54%
Price To Free Cash Flow Ratio-5.068-39%-3.641-6.688+84%-8.167+124%-6.450+77%-14.035+285%-12.820+252%
Price To Total Gains Ratio-19.656-39%-14.122-31.803+125%-23.430+66%-24.830+76%-18.105+28%5.113-376%
Quick Ratio--12.00313.246-9%22.198-46%22.653-47%32.502-63%19.131-37%
Return On Assets---0.095-0.085-11%-0.074-22%-0.071-25%-0.0950%-0.226+138%
Return On Equity---0.103-0.091-11%-0.078-24%-0.075-27%-0.109+6%-0.298+189%
Total Gains Per Share---0.048-0.040-17%-0.053+12%-0.045-5%0.025-294%0.012-484%
Usd Book Value--65322000.00072660500.000-10%94975750.000-31%96323083.333-32%94985172.100-31%51711938.300+26%
Usd Book Value Change Per Share---0.048-0.040-17%-0.053+12%-0.045-5%0.021-326%0.011-547%
Usd Book Value Per Share--0.5060.563-10%0.735-31%0.746-32%0.735-31%0.400+26%
Usd Dividend Per Share----0%-0%-0%0.003-100%0.002-100%
Usd Enterprise Value--146609495.692206881648.173-29%238159626.250-38%219415786.391-33%307596721.735-52%237020329.642-38%
Usd Eps---0.052-0.051-2%-0.057+10%-0.055+5%-0.050-4%-0.039-25%
Usd Free Cash Flow---5968000.000-5578250.000-7%-4659250.000-22%-5322333.333-11%-4679344.850-22%-3450564.275-42%
Usd Free Cash Flow Per Share---0.046-0.043-7%-0.036-22%-0.041-11%-0.036-22%-0.027-42%
Usd Free Cash Flow To Equity Per Share---0.046-0.036-21%-0.013-72%-0.019-59%0.036-229%0.023-302%
Usd Market Cap120980622.000+28%86918495.692139729648.173-38%151015876.250-42%131109703.058-34%218879856.835-60%189374522.442-54%
Usd Price Per Share0.937+28%0.6731.082-38%1.169-42%1.015-34%1.695-60%1.466-54%
Usd Profit---6718000.000-6586000.000-2%-7422750.000+10%-6908833.333+3%-6160876.600-8%-4543154.025-32%
Usd Revenue----0%4500.000-100%1500.000-100%900.000-100%-179785.5250%
Usd Total Gains Per Share---0.048-0.040-17%-0.053+12%-0.045-5%0.025-294%0.012-484%
 EOD+5 -3MRQTTM+3 -29YOY+11 -233Y+7 -275Y+5 -3110Y+11 -24

3.3 Fundamental Score

Let's check the fundamental score of Atossa Genetics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-4.502
Price to Book Ratio (EOD)Between0-11.852
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than112.003
Current Ratio (MRQ)Greater than112.672
Debt to Asset Ratio (MRQ)Less than10.077
Debt to Equity Ratio (MRQ)Less than10.083
Return on Equity (MRQ)Greater than0.15-0.103
Return on Assets (MRQ)Greater than0.05-0.095
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Atossa Genetics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.930
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About Atossa Genetics Inc

Atossa Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States. The company's lead drug candidate is oral (Z)-endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It also develops immunotherapy/chimeric antigen receptor therapy programs. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is based in Seattle, Washington.

Fundamental data was last updated by Penke on 2025-07-10 21:32:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Atossa Genetics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Atossa Genetics Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Atossa Genetics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-8,163.9%+8,163.9%
TTM-5Y-1,632.8%+1,632.8%
5Y-1,632.8%10Y-829.9%-802.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--90.3%+90.3%
TTM--139.0%+139.0%
YOY-8,163.9%-195.4%-7,968.5%
3Y-2,721.3%-247.7%-2,473.6%
5Y-1,632.8%-344.1%-1,288.7%
10Y-829.9%-488.1%-341.8%
4.3.1.2. Return on Assets

Shows how efficient Atossa Genetics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Atossa Genetics Inc to the Biotechnology industry mean.
  • -9.5% Return on Assets means that Atossa Genetics Inc generated $-0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Atossa Genetics Inc:

  • The MRQ is -9.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -8.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-9.5%TTM-8.5%-1.0%
TTM-8.5%YOY-7.4%-1.1%
TTM-8.5%5Y-9.5%+1.0%
5Y-9.5%10Y-22.6%+13.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.5%-11.5%+2.0%
TTM-8.5%-11.5%+3.0%
YOY-7.4%-11.4%+4.0%
3Y-7.1%-11.7%+4.6%
5Y-9.5%-11.9%+2.4%
10Y-22.6%-13.6%-9.0%
4.3.1.3. Return on Equity

Shows how efficient Atossa Genetics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Atossa Genetics Inc to the Biotechnology industry mean.
  • -10.3% Return on Equity means Atossa Genetics Inc generated $-0.10 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Atossa Genetics Inc:

  • The MRQ is -10.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -9.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-10.3%TTM-9.1%-1.2%
TTM-9.1%YOY-7.8%-1.4%
TTM-9.1%5Y-10.9%+1.7%
5Y-10.9%10Y-29.8%+18.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-10.3%-13.6%+3.3%
TTM-9.1%-14.8%+5.7%
YOY-7.8%-14.4%+6.6%
3Y-7.5%-16.8%+9.3%
5Y-10.9%-17.5%+6.6%
10Y-29.8%-19.5%-10.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Atossa Genetics Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Atossa Genetics Inc is operating .

  • Measures how much profit Atossa Genetics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Atossa Genetics Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Atossa Genetics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-9,694.4%+9,694.4%
TTM-5Y-1,938.9%+1,938.9%
5Y-1,938.9%10Y-982.8%-956.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--214.6%+214.6%
TTM--249.7%+249.7%
YOY-9,694.4%-208.5%-9,485.9%
3Y-3,231.5%-218.7%-3,012.8%
5Y-1,938.9%-342.8%-1,596.1%
10Y-982.8%-462.5%-520.3%
4.3.2.2. Operating Ratio

Measures how efficient Atossa Genetics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Atossa Genetics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY96.944-96.944
TTM-5Y19.389-19.389
5Y19.38910Y9.921+9.468
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.093-2.093
TTM-2.680-2.680
YOY96.9443.076+93.868
3Y32.3153.518+28.797
5Y19.3894.734+14.655
10Y9.9216.445+3.476
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Atossa Genetics Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Atossa Genetics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 12.67 means the company has $12.67 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Atossa Genetics Inc:

  • The MRQ is 12.672. The company is very able to pay all its short-term debts. +2
  • The TTM is 13.828. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ12.672TTM13.828-1.156
TTM13.828YOY23.196-9.368
TTM13.8285Y33.678-19.850
5Y33.67810Y19.881+13.797
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ12.6723.616+9.056
TTM13.8283.830+9.998
YOY23.1964.140+19.056
3Y23.7664.688+19.078
5Y33.6785.722+27.956
10Y19.8816.144+13.737
4.4.3.2. Quick Ratio

Measures if Atossa Genetics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Atossa Genetics Inc to the Biotechnology industry mean.
  • A Quick Ratio of 12.00 means the company can pay off $12.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Atossa Genetics Inc:

  • The MRQ is 12.003. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 13.246. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ12.003TTM13.246-1.243
TTM13.246YOY22.198-8.953
TTM13.2465Y32.502-19.256
5Y32.50210Y19.131+13.371
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ12.0032.826+9.177
TTM13.2463.104+10.142
YOY22.1983.786+18.412
3Y22.6534.311+18.342
5Y32.5025.702+26.800
10Y19.1316.335+12.796
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Atossa Genetics Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Atossa Genetics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Atossa Genetics Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.08 means that Atossa Genetics Inc assets are financed with 7.7% credit (debt) and the remaining percentage (100% - 7.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Atossa Genetics Inc:

  • The MRQ is 0.077. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.070. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.077TTM0.070+0.006
TTM0.070YOY0.045+0.026
TTM0.0705Y0.067+0.003
5Y0.06710Y0.138-0.071
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0770.327-0.250
TTM0.0700.349-0.279
YOY0.0450.332-0.287
3Y0.0480.340-0.292
5Y0.0670.346-0.279
10Y0.1380.378-0.240
4.5.4.2. Debt to Equity Ratio

Measures if Atossa Genetics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Atossa Genetics Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 8.3% means that company has $0.08 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Atossa Genetics Inc:

  • The MRQ is 0.083. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.076. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.083TTM0.076+0.007
TTM0.076YOY0.047+0.029
TTM0.0765Y0.082-0.007
5Y0.08210Y0.185-0.102
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0830.383-0.300
TTM0.0760.438-0.362
YOY0.0470.414-0.367
3Y0.0510.450-0.399
5Y0.0820.457-0.375
10Y0.1850.512-0.327
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Atossa Genetics Inc generates.

  • Above 15 is considered overpriced but always compare Atossa Genetics Inc to the Biotechnology industry mean.
  • A PE ratio of -3.23 means the investor is paying $-3.23 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Atossa Genetics Inc:

  • The EOD is -4.502. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.235. Based on the earnings, the company is expensive. -2
  • The TTM is -5.295. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.502MRQ-3.235-1.268
MRQ-3.235TTM-5.295+2.060
TTM-5.295YOY-5.378+0.083
TTM-5.2955Y-10.066+4.771
5Y-10.06610Y-2.125-7.941
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.502-2.416-2.086
MRQ-3.235-2.085-1.150
TTM-5.295-2.620-2.675
YOY-5.378-3.760-1.618
3Y-4.778-3.762-1.016
5Y-10.066-6.363-3.703
10Y-2.125-7.055+4.930
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Atossa Genetics Inc:

  • The EOD is -5.068. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.641. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -6.688. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.068MRQ-3.641-1.427
MRQ-3.641TTM-6.688+3.047
TTM-6.688YOY-8.167+1.479
TTM-6.6885Y-14.035+7.347
5Y-14.03510Y-12.820-1.216
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-5.068-3.300-1.768
MRQ-3.641-2.737-0.904
TTM-6.688-3.792-2.896
YOY-8.167-4.346-3.821
3Y-6.450-5.095-1.355
5Y-14.035-8.478-5.557
10Y-12.820-9.296-3.524
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Atossa Genetics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.33 means the investor is paying $1.33 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Atossa Genetics Inc:

  • The EOD is 1.852. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.331. Based on the equity, the company is underpriced. +1
  • The TTM is 1.905. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.852MRQ1.331+0.521
MRQ1.331TTM1.905-0.574
TTM1.905YOY1.620+0.285
TTM1.9055Y6.277-4.372
5Y6.27710Y14.291-8.014
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.8522.119-0.267
MRQ1.3311.856-0.525
TTM1.9052.125-0.220
YOY1.6202.439-0.819
3Y1.4552.485-1.030
5Y6.2773.667+2.610
10Y14.2914.337+9.954
4.6.2. Total Gains per Share

2.4. Latest News of Atossa Genetics Inc

Does Atossa Genetics Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Atossa Genetics Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-06-22
10:30
BofA assesses the impact of foreign tax in budget bill on European software namesRead

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Atossa Genetics Inc.

4.8.1. Institutions holding Atossa Genetics Inc

Institutions are holding 26.578% of the shares of Atossa Genetics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31BlackRock Inc7.45170.00019625365-134184-1.3749
2025-03-31Vanguard Group Inc5.09860.00016585912-33057-0.4994
2025-03-31Geode Capital Management, LLC2.20310.00022845792316151.1234
2025-03-31Renaissance Technologies Corp1.43620.0019185510129746919.0975
2025-03-31State Street Corp1.33710.00011727090-28279-1.611
2025-03-31Northern Trust Corp0.7540.0001973998-51726-5.0429
2025-03-31Squarepoint Ops LLC0.37080.00044789994789990
2025-03-31UBS Group AG0.35250.0001455386-669317-59.5106
2025-03-31Susquehanna International Group, LLP0.34090.000144033521415994.6869
2025-03-31Charles Schwab Investment Management Inc0.32720.000142258212093440.0911
2025-03-31Bank of New York Mellon Corp0.2243028972700
2025-03-31Morgan Stanley - Brokerage Accounts0.220284187-168009-37.154
2025-03-31Connor Clark & Lunn Inv Mgmt Ltd0.14660.000618931900
2025-03-31Goldman Sachs Group Inc0.14550187927-156931-45.506
2024-12-31Nuveen Asset Management, LLC0.13220.000117073300
2025-03-31Nuveen, LLC0.132201707331707330
2025-03-31Rhumbline Advisers0.10050.000112985176336.2454
2025-03-31Barclays PLC0.09950128578-63376-33.0162
2025-03-31JPMorgan Chase & Co0.09210118929-242367-67.0827
2025-03-31Qube Research & Technologies0.07050.000191034-98545-51.981
Total 21.03550.004127171578-324249-1.2%

4.9.2. Funds holding Atossa Genetics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-05-31Vanguard Total Stock Mkt Idx Inv3.04980.0002393944100
2025-05-31iShares Russell 2000 ETF2.43670.004314751800
2025-05-31Vanguard Institutional Extnd Mkt Idx Tr1.29110.0012166774800
2025-03-31Fidelity Small Cap Index0.98990.0036127862800
2025-05-31iShares Russell 2000 Value ETF0.77870.0073100583900
2025-04-30Fidelity Extended Market Index0.49730.0016642325-6139-0.9467
2025-05-31Vanguard Russell 2000 ETF0.48930.003963203056710.9054
2025-05-31State St Russell Sm Cap® Indx SL Cl I0.42560.004954972100
2025-05-31Schwab Small Cap Index0.26520.004334258200
2025-03-31NT R2000 Index Fund - NL0.22420.0033289595-12571-4.1603
2025-05-31iShares Micro-Cap ETF0.19990.025925821300
2025-05-31BlackRock Advantage Small Cap Core Instl0.19110.004824684200
2025-03-31Extended Equity Market Fund K0.18660.00122409947390.3076
2025-03-31NT R2000 Index Fund - DC - NL - 30.17910.0033231348-15163-6.151
2025-05-31iShares Russell 2000 Growth ETF0.17030.001621999700
2025-04-30Fidelity Total Market Index0.16890.000221811800
2025-05-31iShares Russell 2000 Small-Cap Idx Instl0.16390.003921168200
2025-03-31Russell 2500™ Index Fund F0.1610.0014208000-45-0.0216
2025-03-31Russell 2000 Index Non-Lendable Fund E0.13930.00371799052850.1587
2025-04-30Nuveen Small Cap Blend Idx R60.13220.005217073300
Total 12.14010.085515681259-27223-0.2%

5.3. Insider Transactions

Insiders are holding 0.072% of the shares of Atossa Genetics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2025-05-21Steven C QuayBUY112390.88
2025-03-26H. Lawrence RemmelBUY100000.7
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets70,747
Total Liabilities5,425
Total Stockholder Equity65,322
 As reported
Total Liabilities 5,425
Total Stockholder Equity+ 65,322
Total Assets = 70,747

Assets

Total Assets70,747
Total Current Assets68,744
Long-term Assets2,003
Total Current Assets
Cash And Cash Equivalents 65,116
Other Current Assets 3,628
Total Current Assets  (as reported)68,744
Total Current Assets  (calculated)68,744
+/-0
Long-term Assets
Long-term Assets Other 2,003
Long-term Assets  (as reported)2,003
Long-term Assets  (calculated)2,003
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities5,425
Long-term Liabilities0
Total Stockholder Equity65,322
Total Current Liabilities
Accounts payable 1,165
Other Current Liabilities 3,095
Total Current Liabilities  (as reported)5,425
Total Current Liabilities  (calculated)4,260
+/- 1,165
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock23,488
Retained Earnings -218,510
Other Stockholders Equity 260,344
Total Stockholder Equity (as reported)65,322
Total Stockholder Equity (calculated)65,322
+/-0
Other
Capital Stock23,488
Cash and Short Term Investments 65,116
Common Stock Shares Outstanding 129,170
Liabilities and Stockholders Equity 70,747
Net Debt -65,116
Net Invested Capital 65,322
Net Working Capital 63,319



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302009-12-312009-09-30
> Total Assets 
0
85
41
32
15
0
0
4,135
3,072
1,366
843
5,692
6,826
8,912
10,055
13,482
12,009
22,383
19,819
16,772
11,764
13,803
16,561
12,357
6,243
5,100
3,285
6,278
4,144
2,303
4,709
3,635
8,164
5,980
16,578
14,124
11,720
21,025
18,609
16,597
14,490
11,812
10,206
11,438
42,839
141,081
145,868
143,024
141,262
137,478
134,048
126,724
123,532
116,200
108,355
101,695
96,252
91,087
85,858
79,477
76,444
70,747
70,74776,44479,47785,85891,08796,252101,695108,355116,200123,532126,724134,048137,478141,262143,024145,868141,08142,83911,43810,20611,81214,49016,59718,60921,02511,72014,12416,5785,9808,1643,6354,7092,3034,1446,2783,2855,1006,24312,35716,56113,80311,76416,77219,81922,38312,00913,48210,0558,9126,8265,6928431,3663,0724,13500153241850
   > Total Current Assets 
0
0
40
31
10
0
0
4,050
2,945
1,215
701
885
1,989
4,166
5,355
8,595
7,414
17,700
14,674
11,716
9,086
11,367
13,756
9,542
4,295
3,386
1,455
4,564
3,255
1,517
3,976
2,950
7,898
5,735
16,408
13,923
11,549
20,780
18,388
16,401
14,319
11,667
10,062
11,318
42,770
141,031
145,831
142,987
141,240
136,848
133,421
123,395
118,197
110,869
106,003
97,648
92,219
87,055
81,718
77,111
74,457
68,744
68,74474,45777,11181,71887,05592,21997,648106,003110,869118,197123,395133,421136,848141,240142,987145,831141,03142,77011,31810,06211,66714,31916,40118,38820,78011,54913,92316,4085,7357,8982,9503,9761,5173,2554,5641,4553,3864,2959,54213,75611,3679,08611,71614,67417,7007,4148,5955,3554,1661,9898857011,2152,9454,0500010314000
       Cash And Cash Equivalents 
0
84
32
30
10
0
0
3,006
1,911
899
90
419
1,725
1,385
2,487
7,737
6,342
16,591
14,298
11,374
8,501
9,728
11,403
7,839
3,716
2,883
1,191
4,388
3,028
1,167
3,690
2,734
7,217
4,780
15,237
12,936
10,380
19,568
17,059
15,290
12,581
9,351
7,463
9,106
39,554
137,574
142,433
140,041
136,377
131,486
125,537
117,367
110,890
103,868
99,390
94,031
88,570
84,070
79,526
74,766
71,084
65,116
65,11671,08474,76679,52684,07088,57094,03199,390103,868110,890117,367125,537131,486136,377140,041142,433137,57439,5549,1067,4639,35112,58115,29017,05919,56810,38012,93615,2374,7807,2172,7343,6901,1673,0284,3881,1912,8833,7167,83911,4039,7288,50111,37414,29816,5916,3427,7372,4871,3851,725419908991,9113,00600103032840
       Short-term Investments 
0
0
0
0
0
0
0
0
1,000
0
251
250
0
0
0
0
0
0
0
0
0
0
0
275
275
275
55
55
55
55
55
55
55
55
55
55
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000555555555555555555552752752750000000000025025101,00000000000
       Net Receivables 
0
0
0
0
0
0
0
0
1
46
179
175
142
259
520
299
139
91
48
29
298
1,280
2,012
1,055
76
76
268
228
194
149
3
4
358
396
626
480
518
238
406
569
740
734
761
439
635
720
817
935
1,072
668
900
610
743
738
737
28
-1
0
-1,095
0
0
0
000-1,0950-1287377387436109006681,0729358177206354397617347405694062385184806263963584314919422826876761,0552,0121,28029829489113929952025914217517946100000000
       Other Current Assets 
0
0
8
2
0
0
0
1,044
1,033
269
431
290
123
2,521
2,395
559
113
1,018
325
267
532
264
239
477
579
503
264
176
227
350
283
212
322
560
545
507
1,169
973
923
542
998
1,582
1,838
1,773
2,486
2,738
2,581
2,011
3,791
4,694
6,984
5,418
6,564
6,263
5,876
3,589
3,649
1,723
1,097
2,345
3,373
3,628
3,6283,3732,3451,0971,7233,6493,5895,8766,2636,5645,4186,9844,6943,7912,0112,5812,7382,4861,7731,8381,5829985429239731,1695075455603222122833502271762645035794772392645322673251,0181135592,3952,5211232904312691,0331,0440002800
   > Long-term Assets 
0
0
1
1
5
0
0
85
126
151
142
4,807
4,837
4,746
4,700
4,887
4,595
4,683
5,145
5,056
2,678
2,436
2,806
2,815
1,948
1,714
1,830
1,714
890
786
733
685
266
245
170
201
171
245
221
196
170
145
144
119
69
49
37
37
22
630
627
3,329
5,335
5,331
2,352
4,047
4,033
4,032
4,140
2,366
1,987
2,003
2,0031,9872,3664,1404,0324,0334,0472,3525,3315,3353,32962763022373749691191441451701962212451712011702452666857337868901,7141,8301,7141,9482,8152,8062,4362,6785,0565,1454,6834,5954,8874,7004,7464,8374,807142151126850051100
       Property Plant Equipment 
0
0
0
0
0
0
0
34
80
76
72
67
160
150
206
443
163
130
128
185
358
382
360
485
172
146
114
85
55
28
19
14
11
60
61
58
54
136
120
102
84
67
74
57
39
24
19
23
20
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000002023192439577467841021201365458616011141928558511414617248536038235818512813016344320615016067727680340000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,700
4,700
4,700
1,710
1,710
0
1,710
1,710
0
0
0
0001,7101,71001,7101,7104,7004,7002,700000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
45
41
37
32
4,703
4,640
4,559
4,458
4,407
4,396
4,492
4,454
4,365
1,921
1,878
1,822
1,769
1,701
1,492
1,447
1,402
640
610
586
561
76
71
60
55
99
92
84
76
69
61
53
45
13
9
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000049134553616976849299556071765615866106401,4021,4471,4921,7011,7691,8221,8781,9214,3654,4544,4924,3964,4074,4584,5594,6404,703323741450000000
       Other Assets 
0
1
0
0
5
0
0
0
46
0
70
4,740
4,677
4,596
4,494
4,444
4,432
4,553
5,017
4,871
2,320
2,054
2,445
2,330
1,776
1,568
1,715
1,629
834
758
714
671
255
115
49
89
17
17
17
17
0
17
17
74
56
16
13
13
2
630
627
0
635
0
0
0
0
0
0
0
0
0
000000000635062763021313165674171701717171789491152556717147588341,6291,7151,5681,7762,3302,4452,0542,3204,8715,0174,5534,4324,4444,4944,5964,6774,7407004600050010
> Total Liabilities 
0
0
98
559
867
0
0
1,399
1,512
779
1,398
2,291
1,651
1,936
1,774
1,942
1,407
1,082
1,563
1,540
2,266
3,519
3,436
3,298
2,502
1,327
874
864
1,047
775
1,906
1,072
1,225
721
3,011
3,555
2,915
1,529
1,057
1,578
1,334
916
1,831
1,567
15,672
1,379
1,796
1,676
3,126
2,322
3,792
2,868
5,568
2,944
3,478
3,444
5,236
5,328
5,696
5,796
4,967
5,425
5,4254,9675,7965,6965,3285,2363,4443,4782,9445,5682,8683,7922,3223,1261,6761,7961,37915,6721,5671,8319161,3341,5781,0571,5292,9153,5553,0117211,2251,0721,9067751,0478648741,3272,5023,2983,4363,5192,2661,5401,5631,0821,4071,9421,7741,9361,6512,2911,3987791,5121,399008675599800
   > Total Current Liabilities 
0
54
98
559
867
0
0
1,399
1,512
779
1,398
2,291
1,651
1,936
1,774
1,942
1,407
1,082
1,563
1,540
2,214
3,487
3,414
3,293
2,502
1,327
874
864
1,047
775
1,906
1,072
1,225
721
3,011
3,555
2,915
1,491
1,033
1,564
1,323
908
1,827
1,565
15,672
1,379
1,796
1,676
3,126
2,322
3,792
2,868
5,568
2,944
3,478
3,444
5,236
5,328
5,696
5,796
4,967
5,425
5,4254,9675,7965,6965,3285,2363,4443,4782,9445,5682,8683,7922,3223,1261,6761,7961,37915,6721,5651,8279081,3231,5641,0331,4912,9153,5553,0117211,2251,0721,9067751,0478648741,3272,5023,2933,4143,4872,2141,5401,5631,0821,4071,9421,7741,9361,6512,2911,3987791,5121,3990086755998540
       Short-term Debt 
0
0
5
107
189
0
0
1,010
1,005
250
250
250
0
0
1,486
1,427
10
0
0
0
76
80
72
0
0
0
0
0
0
0
0
0
0
0
0
0
0
101
104
99
79
59
79
60
36
8
9
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000029836607959799910410100000000000000728076000101,4271,486002502502501,0051,01000189107500
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
51
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000510000000000000000000000000000000000000
       Accounts payable 
0
0
0
0
0
0
0
0
65
97
71
72
68
35
184
31
248
196
790
439
513
966
581
1,179
814
429
283
197
254
387
496
380
335
168
191
551
353
464
318
501
293
356
1,033
683
1,589
722
538
668
1,717
1,596
2,052
1,653
2,965
1,444
1,174
718
806
1,230
1,056
1,561
679
1,165
1,1656791,5611,0561,2308067181,1741,4442,9651,6532,0521,5961,7176685387221,5896831,0333562935013184643535511911683353804963872541972834298141,1795819665134397901962483118435687271976500000000
       Other Current Liabilities 
0
49
93
452
678
0
0
389
355
433
1,077
1,969
1,564
1,893
1,490
1,891
1,130
1,069
761
1,087
1,431
2,216
2,550
1,877
1,593
788
504
666
727
388
1,410
691
891
552
2,820
3,005
2,562
926
611
964
951
493
715
823
14,047
649
1,249
1,005
1,409
726
1,740
1,215
2,603
1,500
2,304
2,726
4,430
4,098
4,640
4,235
4,288
3,095
3,0954,2884,2354,6404,0984,4302,7262,3041,5002,6031,2151,7407261,4091,0051,24964914,0478237154939519646119262,5623,0052,8205528916911,4103887276665047881,5931,8772,5502,2161,4311,0877611,0691,1301,8911,4901,8931,5641,9691,0774333553890067845293490
   > Long-term Liabilities 
0
0
5
107
189
0
0
1,010
1,070
347
321
322
68
35
257
92
58
35
790
439
52
32
23
6
814
429
283
197
254
387
496
380
335
168
191
551
353
37
24
14
11
8
5
1
1,607
730
543
669
1,717
1,596
2,052
1,653
2,965
1,444
0
0
0
0
0
0
0
0
000000001,4442,9651,6532,0521,5961,7176695437301,60715811142437353551191168335380496387254197283429814623325243979035589225735683223213471,0701,01000189107500
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
49
25
13
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000000013254900000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
7
10
5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000005107200000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
7
10
6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000006107200000000000000000000
> Total Stockholder Equity
0
0
-57
-527
-852
0
0
2,736
1,560
587
-555
3,402
5,176
6,976
8,281
11,540
10,602
21,301
18,256
15,233
9,498
10,284
13,125
9,059
3,742
3,773
2,410
5,414
3,097
1,528
2,804
2,563
6,939
5,260
13,567
10,569
8,805
19,496
17,552
15,018
13,156
10,896
8,374
9,871
27,168
139,701
144,072
141,348
138,136
135,156
130,256
123,856
117,964
113,256
104,877
98,251
91,016
85,759
80,162
73,681
71,477
65,322
65,32271,47773,68180,16285,75991,01698,251104,877113,256117,964123,856130,256135,156138,136141,348144,072139,70127,1689,8718,37410,89613,15615,01817,55219,4968,80510,56913,5675,2606,9392,5632,8041,5283,0975,4142,4103,7733,7429,05913,12510,2849,49815,23318,25621,30110,60211,5408,2816,9765,1763,402-5555871,5602,73600-852-527-5700
   Common Stock
0
5
6
6
6
0
0
11
11
11
11
12
13
15
15
17
19
24
24
25
25
27
29
30
33
39
40
57
57
57
150
210
477
477
877
994
1,052
1,642
1,643
1,644
1,644
1,644
1,675
1,884
8,559
21,748
22,667
22,792
22,792
22,792
22,792
22,792
22,792
22,792
22,792
22,792
22,792
22,829
22,874
22,882
23,488
23,488
23,48823,48822,88222,87422,82922,79222,79222,79222,79222,79222,79222,79222,79222,79222,79222,66721,7488,5591,8841,6751,6441,6441,6441,6431,6421,05299487747747721015057575740393330292725252424191715151312111111110066650
   Retained Earnings Total Equity0000000-172,305-162,475-156,194-148,703-140,691-134,020-129,234-124,402-119,205-112,166-111,899-104,416-100,925-97,018-94,071-91,453-88,167-80,905-76,831-74,753-71,443-67,301-65,426-63,433-61,249-59,007-57,304-54,780-54,985-53,262-50,935-45,973-41,655-38,510-35,175-29,362-26,116-22,928-20,517-17,759-14,257-11,673-9,732-8,02600000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
-1
0
-10
-15
-19
-31
-41
-67
-94
-272
-294
-313
-338
-259
-290
-322
-356
-114
-144
-176
-206
-155
-143
-152
-156
-159
0
0
0
0
0
0
0
-151
-151
0
0
0
0
0
0
-582
-582
0
-54
-582
0
-582
254,886
0
0
0
0
0
0
000000254,886-5820-582-540-582-582000000-151-1510000000-159-156-152-143-155-206-176-144-114-356-322-290-259-338-313-294-272-94-67-41-31-19-15-100-10000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
11,416
14,895
18,634
22,523
29,281
31,100
44,205
44,347
44,570
44,648
48,766
54,751
55,002
54,644
56,997
57,356
60,138
60,344
60,479
63,872
65,786
71,888
72,083
78,331
84,328
84,584
98,759
104,076
104,828
105,583
106,271
107,624
112,403
130,508
230,119
240,610
242,958
244,578
246,384
248,155
249,821
251,366
252,939
254,542
0
0
0
0
0
0
0
0000000254,542252,939251,366249,821248,155246,384244,578242,958240,610230,119130,508112,403107,624106,271105,583104,828104,07698,75984,58484,32878,33172,08371,88865,78663,87260,47960,34460,13857,35656,99754,64455,00254,75148,76644,64844,57044,34744,20531,10029,28122,52318,63414,89511,41600000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
322
335
352
0
0
6,172
6,201
6,290
6,331
11,416
14,895
18,634
22,523
29,281
31,100
44,205
44,347
44,570
44,648
48,766
54,751
55,002
54,644
56,997
57,356
60,138
60,344
60,479
63,902
65,786
71,888
72,083
84,133
84,328
84,584
98,759
104,076
104,828
105,583
106,271
107,624
112,403
129,887
230,119
240,610
242,958
243,996
245,802
247,573
249,239
250,784
252,357
253,808
253,411
254,512
255,096
255,503
256,244
259,781
260,344
260,344259,781256,244255,503255,096254,512253,411253,808252,357250,784249,239247,573245,802243,996242,958240,610230,119129,887112,403107,624106,271105,583104,828104,07698,75984,58484,32884,13372,08371,88865,78663,90260,47960,34460,13857,35656,99754,64455,00254,75148,76644,64844,57044,34744,20531,10029,28122,52318,63414,89511,4166,3316,2906,2016,1720035233532200



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-17
Gross Profit-17-17
 
Operating Income (+$)
Gross Profit-17
Operating Expense-27,604
Operating Income-27,621-27,621
 
Operating Expense (+$)
Research Development14,117
Selling General Administrative13,504
Selling And Marketing Expenses0
Operating Expense27,60427,621
 
Net Interest Income (+$)
Interest Income4,050
Interest Expense-0
Other Finance Cost-0
Net Interest Income4,050
 
Pretax Income (+$)
Operating Income-27,621
Net Interest Income4,050
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-25,504-29,738
EBIT - interestExpense = -25,504
-25,504
-25,504
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-25,504-25,504
Earnings Before Interest and Taxes (EBITDA)-25,487
 
After tax Income (+$)
Income Before Tax-25,504
Tax Provision-0
Net Income From Continuing Ops-25,504-25,504
Net Income-25,504
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses27,621
Total Other Income/Expenses Net2,117-4,050
 

Technical Analysis of Atossa Genetics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Atossa Genetics Inc. The general trend of Atossa Genetics Inc is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Atossa Genetics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Atossa Genetics Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Atossa Genetics Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 1.02 < 1.07 < 1.08.

The bearish price targets are: 0.934 > 0.92 > 0.77.

Know someone who trades $ATOS? Share this with them.👇

Atossa Genetics Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Atossa Genetics Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Atossa Genetics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Atossa Genetics Inc.

Atossa Genetics Inc Daily Moving Average Convergence/Divergence (MACD) ChartAtossa Genetics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Atossa Genetics Inc. The current adx is .

Atossa Genetics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Atossa Genetics Inc.

Atossa Genetics Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Atossa Genetics Inc.

Atossa Genetics Inc Daily Relative Strength Index (RSI) ChartAtossa Genetics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Atossa Genetics Inc.

Atossa Genetics Inc Daily Stochastic Oscillator ChartAtossa Genetics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Atossa Genetics Inc.

Atossa Genetics Inc Daily Commodity Channel Index (CCI) ChartAtossa Genetics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Atossa Genetics Inc.

Atossa Genetics Inc Daily Chande Momentum Oscillator (CMO) ChartAtossa Genetics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Atossa Genetics Inc.

Atossa Genetics Inc Daily Williams %R ChartAtossa Genetics Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Atossa Genetics Inc.

Atossa Genetics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Atossa Genetics Inc.

Atossa Genetics Inc Daily Average True Range (ATR) ChartAtossa Genetics Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Atossa Genetics Inc.

Atossa Genetics Inc Daily On-Balance Volume (OBV) ChartAtossa Genetics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Atossa Genetics Inc.

Atossa Genetics Inc Daily Money Flow Index (MFI) ChartAtossa Genetics Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Atossa Genetics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-03-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-03-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-03STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-04-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-25BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-04-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-29STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-04-30ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-01RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-02MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-05STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-05-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-13WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-05-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-05-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-30STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-06-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-06-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-09STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-07-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-07-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.

6.3. Candlestick Patterns

Atossa Genetics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Atossa Genetics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.930
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Atossa Genetics Inc with someone you think should read this too:
  • Are you bullish or bearish on Atossa Genetics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Atossa Genetics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Atossa Genetics Inc

I send you an email if I find something interesting about Atossa Genetics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Atossa Genetics Inc.

Receive notifications about Atossa Genetics Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.